[HTML][HTML] Potential treatments for COVID-19; a narrative literature review
A Rismanbaf - Archives of academic emergency medicine, 2020 - ncbi.nlm.nih.gov
SARS-CoV-2 is a newly emerging human infectious coronavirus that causes COVID-19,
which has been recognized as a pandemic by the World Health Organization (WHO) on …
which has been recognized as a pandemic by the World Health Organization (WHO) on …
[HTML][HTML] Interim guidelines on antiviral therapy for COVID-19
SB Kim, K Huh, JY Heo, EJ Joo, YJ Kim… - Infection & …, 2020 - ncbi.nlm.nih.gov
Since the first case was reported in Wuhan, Hubei Province, China on December 12, 2019,
Coronavirus disease 2019 (COVID-19) has spread widely to other countries since January …
Coronavirus disease 2019 (COVID-19) has spread widely to other countries since January …
Outcomes evaluated in controlled clinical trials on the management of COVID-19: a methodological systematic review
AG Mathioudakis, M Fally, R Hashad, A Kouta, AS Hadi… - Life, 2020 - mdpi.com
It is crucial that randomized controlled trials (RCTs) on the management of coronavirus
disease 2019 (COVID-19) evaluate the outcomes that are critical to patients and clinicians …
disease 2019 (COVID-19) evaluate the outcomes that are critical to patients and clinicians …
Evaluation of the current therapeutic approaches for COVID-19: a systematic review and a meta-analysis
Z Abdelrahman, Q Liu, S Jiang, M Li, Q Sun… - Frontiers in …, 2021 - frontiersin.org
Background: Limited data on the efficacy and safety of currently applied COVID-19
therapeutics and their impact on COVID-19 outcomes have raised additional concern …
therapeutics and their impact on COVID-19 outcomes have raised additional concern …
Early treatment of COVID-19 disease: a missed opportunity
Antivirals have demonstrated efficacy in treating other infectious diseases in early stages of
disease, reducing morbidity, mortality, and the likelihood of onward transmission. At the time …
disease, reducing morbidity, mortality, and the likelihood of onward transmission. At the time …
[HTML][HTML] Recent advances in management of COVID-19: A review
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused and is still causing
significant mortality and economic consequences all over the globe. As of today, there are …
significant mortality and economic consequences all over the globe. As of today, there are …
[HTML][HTML] Pharmacologicaltreatment of COVID-19: lights and shadows
F Menzella, M Biava, C Barbieri, F Livrieri… - Drugs in …, 2020 - ncbi.nlm.nih.gov
At the end of December 2019, a novel coronavirus, the severe acute respiratory syndrome
coronavirus 2, caused an outbreak of pneumonia spreading from Wuhan, Hubei province, to …
coronavirus 2, caused an outbreak of pneumonia spreading from Wuhan, Hubei province, to …
[HTML][HTML] Therapeutic management of patients with COVID-19: a systematic review
M Tobaiqy, M Qashqary, S Al-Dahery… - Infection Prevention in …, 2020 - Elsevier
Background Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the
causative agent of coronavirus disease 2019 (COVID-19), which was declared a global …
causative agent of coronavirus disease 2019 (COVID-19), which was declared a global …
[PDF][PDF] COVID-19 drug therapy
T Smith, J Bushek, A LeClaire, T Prosser - Elsevier, 2020 - repository.phb.ac.id
• There are no specific therapies approved by the US Food and Drug Administration (FDA)
for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes …
for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes …